SHANGHAI, 13. Juni 2026 /PRNewswire/ -- Am 29. Mai 2026 (Pacific Time) schloss die Simcere Pharmaceutical Group Limited (2096.HK) eine Forschungskooperationsvereinbarung mit Stanford Medicine ab, um gemeinsam eine explorative Studie im Bereich der Atemwegserkrankungen voranzutreiben, mit...
Hence then, the article about simcere pharmaceutical schliesst eine forschungskooperationsvereinbarung mit stanford medicine zur entwicklung innovativer therapien fur patienten mit idiopathischer lungenfibrose was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Simcere Pharmaceutical schließt eine Forschungskooperationsvereinbarung mit Stanford Medicine zur Entwicklung innovativer Therapien für Patienten mit idiopathischer Lungenfibrose )
Also on site :
- Greg Evigan Shares Sweet ‘My Two Dads’ Throwback With Paul Reiser and Staci Keanan: ‘I Adore These 2 People!’
- Carole King Wrote ‘Will You Love Me Tomorrow’ at 18 and It Became the First No. 1 Song by Any Girl Group; She Sang It 11 Years Later on Tapestry
- Aaron Sorkin Says Jeremy Strong Treated His Co-Stars ‘The Way He Imagines’ Mark Zuckerberg Treats People While Shooting ‘The Social Reckoning’